A case series of severe hyperammonemia encephalopathy related to valproate: Can antipsychotics increase the risk?

9Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Valproate-induced hyperammonemia is a common side effect of valproate, which may occur either without any symptoms or may rarely cause symptoms of encephalopathy. Different risk factors have been defined for this side effect, including some nutritional deficiencies and polypharmacy (eg, other anticonvulsants). Three cases with psychiatric disorder who showed symptoms of severe hyperammonemia encephalopathy and had taken valproate with antipsychotics, especially risperidone, are presented here. In all cases, the symptoms were improved by discontinuation of valproate. Administration of antipsychotic may be considered as a risk factor for hyperammonemic encephalopathy related to valproate, specifically in some prone populations.

Cite

CITATION STYLE

APA

Davoudi-Monfared, E., Radmehr, M., Ghaeli, P., & Mousavi, M. (2019). A case series of severe hyperammonemia encephalopathy related to valproate: Can antipsychotics increase the risk? Iranian Journal of Psychiatry, 14(3), 248–252. https://doi.org/10.18502/ijps.v14i3.1342

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free